This review shows the evolution of ventricular assist devices and their complications in heart failure, highlighting future technologies suggesting broader adoption.
Key Points
Ventricular assist devices provide lifesaving therapy for advanced heart failure, approaching survival rates of transplants.
Despite advancements, complications such as pump thrombosis and infections can significantly impact patient outcomes and healthcare costs.
Research focuses on improving bio-compatibility and reducing hemocompatibility-related adverse events to enhance patient safety.
Emerging technologies like machine learning-based monitoring can support the future of mechanical circulatory support in heart failure patients.